2014's Information

2014/03/19

Notice for completion of the registration of incorporation of a subsidiary

2014/02/27

Notice of Changing of Accounting Auditor

2014/02/27

Announcement of the 13th Annual General Shareholder Meeting

2014/02/27

Notice for the drug price and sales commencement for Etuary

2014/02/03

Notice for Exercise of the 37th Round of Stock Options in January, 2014

2014/01/27

Notice for establishment of distributors

2014/01/17

Notice for Large Volume Exercise and Completion of the 37th Round of Stock Option

2014/01/14

Notice for F647 commercial name

2014/01/06

GNI Group Receives Manufacture Approval for F647 from China FDA for First Idiopathic Pulmonary Fibrosis Drug in China

2014/01/06

（Amendment）GNI Group Receives Manufacture Approval for F647 from China FDA for First Idiopathic Pulmonary Fibrosis Drug in China